Stroke
Conditions
Interventions
Experimental Group 1-cerebellum:HD-tDCS stimulation was applied to the cerebellum using Starstim 8 (Neuroelectrics, Spain) equipment. Referring to previous studies, the anode was placed at Iz, and the
Experimental Group 2-M1:HD-tDCS stimulation was applied to M1 using Starstim 8 (Neuroelectrics, Spain) equipment. Based on previous studies, the anode was placed at Cz, and the cathode was placed at F
Control group:0 mA, ensuring the placebo effect.
Sponsors
The Sixth Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Confirmed by cranial CT and MRI imaging as a stroke, with the first episode occurring; 2.Disease duration of 1 month = 17 points; 6.No unilateral neglect; 7.Berg Balance Scale (BBS) >= 20 points; 8.Voluntary participation and signed informed consent.
Exclusion criteria
Exclusion criteria: 1.Individuals with neural implants or pacemakers; 2.Those who have undergone neurological electrotherapy within the past two weeks; 3.Those with cranial defects in the frontal or parietal regions; 4.Those unable to cooperate with the wearing of a near-infrared brain function detection cap; 5.Those with severe conditions such as heart, lung, liver, or kidney damage who cannot tolerate the procedure; 6.Those with mental disorders, hearing impairments, comprehension impairments, or visual impairments; 7.Those with spinal instability or unstable fractures; 8.Those with deep vein thrombosis in the lower limbs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oxyhemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Limits of Stability ,LOS;Center of Pressure, COP; | — |
Countries
China
Contacts
Public ContactYuling Wang
The Sixth Affliated Hospital, Sun Yat-senUniversity
Outcome results
None listed